Risk factors for lymphoproliferation and mortality in Sjögren’s syndrome

Author： Voulgarelis Michael   Tzioufas Athanasios G  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.1, Iss.5, 2006-10, pp. : 607-616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sjögren’s syndrome

By Moutsopoulos Haralampos M   Tzioufas Athanasios G  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 5, 2013-10 ,pp. : 517-520

Future Medicine

Access to resources Recommend Favorite

Thyroid disease in Sjögren’s syndrome

By Jara Luis   Navarro Carmen   Brito-Zerón María del   García-Carrasco Mario   Escárcega Ricardo   Ramos-Casals Manuel  

Clinical Rheumatology, Vol. 26, Iss. 10, 2007-10 ,pp. : 1601-1606

Springer Publishing Company

Access to resources Recommend Favorite

Proceedings of the Sjögren’s syndrome Foundation National Conference

By Carsons Steven   Vivino Frederick B  

Future Rheumatology, Vol. 2, Iss. 4, 2007-08 ,pp. : 373-378

Future Medicine

Access to resources Recommend Favorite

Efficacy prediction of cevimeline in patients with Sjögren’s syndrome

By Yamada Hiroyuki   Nakagawa Yoichi   Wakamatsu Ei   Sumida Takayuki   Yamachika Shigeo   Nomura Yoshiaki   Mishima Kenji   Saito Ichiro  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1320-1327

Springer Publishing Company

Access to resources Recommend Favorite

Sjögren’s syndrome in patients with ankylosing spondylitis

By Kobak Senol   Celebi Kobak Arzu   Kabasakal Yasemin   Doganavsargil Eker  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 173-175

Springer Publishing Company

Access to resources Recommend Favorite